Covered recipient · General Payments record
JONATHAN S FORMAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2020
$135.85
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $94.40 | 16 |
| Food and Beverage | $41.45 | 2 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amarin Pharma Inc. | $111.26 | 17 |
| RedHill Biopharma Inc. | $24.59 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2020 | $135.85 | 18 |
Payment records · PY2020 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amarin Pharma Inc. | $5.90 | 01/06/2020 | Education | Undisputed | 01/23/2026 | 739931943 | CMS |
| Amarin Pharma Inc. | $5.90 | 01/21/2020 | Education | Undisputed | 01/23/2026 | 740063071 | CMS |
| Amarin Pharma Inc. | $5.90 | 02/05/2020 | Education | Undisputed | 01/23/2026 | 739931939 | CMS |
| Amarin Pharma Inc. | $5.90 | 02/19/2020 | Education | Undisputed | 01/23/2026 | 739918383 | CMS |
| Amarin Pharma Inc. | $5.90 | 02/27/2020 | Education | Undisputed | 01/23/2026 | 739918389 | CMS |
| Amarin Pharma Inc. | $16.86 | 06/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | 740063067 | CMS |
| Amarin Pharma Inc. | $5.90 | 09/23/2020 | Education | Undisputed | 01/23/2026 | 740063065 | CMS |
| Amarin Pharma Inc. | $5.90 | 09/29/2020 | Education | Undisputed | 01/23/2026 | 739931935 | CMS |
| Amarin Pharma Inc. | $5.90 | 10/16/2020 | Education | Undisputed | 01/23/2026 | 739932027 | CMS |
| Amarin Pharma Inc. | $5.90 | 10/16/2020 | Education | Undisputed | 01/23/2026 | 740063063 | CMS |
| Amarin Pharma Inc. | $5.90 | 10/26/2020 | Education | Undisputed | 01/23/2026 | 740063069 | CMS |
| Amarin Pharma Inc. | $5.90 | 11/09/2020 | Education | Undisputed | 01/23/2026 | 739926637 | CMS |
| Amarin Pharma Inc. | $5.90 | 11/16/2020 | Education | Undisputed | 01/23/2026 | 739918387 | CMS |
| Amarin Pharma Inc. | $5.90 | 11/23/2020 | Education | Undisputed | 01/23/2026 | 739931949 | CMS |
| Amarin Pharma Inc. | $5.90 | 12/08/2020 | Education | Undisputed | 01/23/2026 | 740063061 | CMS |
| Amarin Pharma Inc. | $5.90 | 12/21/2020 | Education | Undisputed | 01/23/2026 | 739926635 | CMS |
| Amarin Pharma Inc. | $5.90 | 12/28/2020 | Education | Undisputed | 01/23/2026 | 739918385 | CMS |
| RedHill Biopharma Inc. | $24.59 | 03/02/2020 | Food and Beverage | Undisputed | 01/23/2026 | 730047123 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020
- Source files
- Dataset page · Bulk file · PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.